Literature DB >> 11961273

Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells.

Jinseu Park1, Jiyoon Ryu1, Kyeong-Ae Kim1, Hak Joo Lee1, Jae Hoon Bahn1, Kyuhyung Han1, Eui Yul Choi1, Kil Soo Lee1, Hyeok Yil Kwon2, Soo Young Choi1.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Tat protein transduction domain (PTD), which contains a high proportion of arginine and lysine residues, is responsible for highly efficient protein transduction through the plasma membrane. To identify the role of the PTD sequence motif in transduction, various deletions and substitutions were introduced into the PTD. Tat-green fluorescent protein (GFP) fusion proteins, containing various lengths of the Tat PTD, were expressed and the extent of their transduction into mammalian cells was analysed by Western blot analysis and fluorescence microscopy. Deletion analysis of PTD mapped to a nine amino acid motif (residues 49-57: RKKRRQRRR) sufficient for transduction. Further deletion of this Tat basic domain either at the N terminus or at the C terminus significantly decreased transduction efficiency. The transduction efficiencies of GFPs fused to nine consecutive lysine (9Lys-GFP) or arginine (9Arg-GFP) residues were similar to that of Tat(49-57)-GFP. The transduced proteins localized to both the nucleus and the cytosol, as assessed by confocal microscopy and Western blot analysis of subcellular fractions from transduced cells. Thus, the availability of recombinant GFP fusion proteins facilitates the simple and specific identification of protein transduction mediated by these peptide sequences. The modified PTD sequences designed in this study may provide useful tools necessary for delivering therapeutic proteins/peptides into cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961273     DOI: 10.1099/0022-1317-83-5-1173

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Chimeric p53 as an alternative therapy for hypoxic tumors.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

2.  The transduction of His-TAT-p53 fusion protein into the human osteogenic sarcoma cell line (Saos-2) and its influence on cell cycle arrest and apoptosis.

Authors:  Lei Jiang; Yushu Ma; Jinzhi Wang; Xinyi Tao; Dongzhi Wei
Journal:  Mol Biol Rep       Date:  2007-01-06       Impact factor: 2.316

3.  Cell-Penetrating Peptides Delivering siRNAs: An Overview.

Authors:  Luca Falato; Maxime Gestin; Ülo Langel
Journal:  Methods Mol Biol       Date:  2021

Review 4.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

5.  Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells.

Authors:  Xia Liu; Baoju Ji; Mengyi Sun; Weijiang Wu; Lili Huang; Aihua Sun; Yangyong Zong; Sheng Xia; Liyun Shi; Hui Qian; Wenrong Xu; Qixiang Shao
Journal:  Clin Exp Immunol       Date:  2015-05-10       Impact factor: 4.330

6.  TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression.

Authors:  Melissa J Simon; Shan Gao; Woo Hyeun Kang; Scott Banta; Barclay Morrison
Journal:  Biotechnol Bioeng       Date:  2009-09-01       Impact factor: 4.530

7.  Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.

Authors:  Xiaoping Zhang; Yongjiu Jin; Mark R Plummer; Shahriar Pooyan; Simi Gunaseelan; Patrick J Sinko
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

8.  Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease.

Authors:  Bita Sahaf; Kondala Atkuri; Kartoosh Heydari; Meena Malipatlolla; Jay Rappaport; Emmanuel Regulier; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

9.  Efficient LRP1-Mediated Uptake and Low Cytotoxicity of Peptide L57 In Vitro Shows Its Promise as CNS Drug Delivery Vector.

Authors:  Jolin P Rodrigues; Neela Prajapati; Mark A DeCoster; Scott Poh; Teresa A Murray
Journal:  J Pharm Sci       Date:  2020-10-14       Impact factor: 3.534

10.  Using molecular dynamics simulations to prioritize and understand AI-generated cell penetrating peptides.

Authors:  Duy Phuoc Tran; Seiichi Tada; Akiko Yumoto; Akio Kitao; Yoshihiro Ito; Takanori Uzawa; Koji Tsuda
Journal:  Sci Rep       Date:  2021-05-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.